Episodes List

Making Sense of Severe Lupus: How the SLE-DAS Tool Could Improve Care Outcomes

04 Aug, 2025

Inside Lupus: The Potential of Genetic Endotypes to Personalize Lupus Care

07 Jul, 2025

Empowering Lupus Patients: A Treatment Measure Shaped by Their Voices

07 May, 2025

Steroid Use for the Treatment of Lupus Nephritis

07 Apr, 2025

Validating Claims Algorithms for SLE: Geospatial Insights and Impacts on Health Disparities

03 Mar, 2025

Rethinking Lupus Nephritis Treatment: Voclosporin vs. High-Dose Steroids

03 Feb, 2025

Rituximab in Childhood Lupus: Insights and Safety

06 Jan, 2025

Managing Pregnancy in Lupus: Contraception Use and Beyond

07 Oct, 2024

Leveraging Positive Psychosocial Factors to Manage Stress in Lupus

02 Sep, 2024

Krill Oil may represent a promising complementary therapy in SLE

05 Aug, 2024

Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development

01 Jul, 2024

Interpreting Hydroxychloroquine Blood Levels in Lupus

03 Jun, 2024

Use of Artificial Intelligence and Machine Learning in Clinical Practice

06 May, 2024

To RNase or Not to RNase: That Is the Question

04 Mar, 2024

A decision-aid facilitates patient understanding of benefits vs. risk of hydroxychloriquine use as part of routine care for lupus

05 Feb, 2024

Dual dsDNA testing may be needed to fully understand patient disease status

01 Jan, 2024

Is Anifrolumab an effective treatment for lupus nephritis?

04 Dec, 2023

Which one is better at controlling lupus: Belimumab or Anifrolumab?

07 Nov, 2023

Managing Lupus Nephritis: Importance of Immunosuppression and Mitigation of Tissue Fibrosis

02 Oct, 2023

Testing a new measure of lupus improvement that encompasses the patients’ perspectives and doctors’ evaluations

04 Sep, 2023

Understanding Lupus: Exploring the Differences between Type 1 and Type 2 Symptoms

07 Aug, 2023

Unpacking Lupus Treatment: How Quickly Does Anifrolumab Start Working? Insights from TULIP Trials

03 Jul, 2023

Biomarker reduction indicates treatment response to Belimumab

24 May, 2023

Reduction in Urinary CD163 Associated with Treatment Response in the Belimumab Lupus Nephritis Trial

18 May, 2023

Biomarker reduction indicates treatment response to Belimumab

18 May, 2023

Mesenchymal stromal cells: a potential new SLE treatment option?

02 Aug, 2022

Mesenchymal stromal cells: a potential new SLE treatment option?

02 Aug, 2022

Using patient registries to estimate SLE incidence rate in the USA

26 May, 2022

Using patient registries to estimate SLE incidence rate in the USA

26 May, 2022

Defining remission in systemic lupus erythematosus

26 May, 2022

Previous 123 Next